4

OWNERSHIP DOCUMENT

Company: Protalix BioTherapeutics, Inc.
Filed: November 3, 2014
Period of Report: September 29, 2014
Accession Number: 0001144204-14-064729

View Document ↗ View on SEC.gov ↗